These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38595149)

  • 21. The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double blind, randomized, placebo-controlled study.
    Kuiken SD; Tytgat GN; Boeckxstaens GE
    Clin Gastroenterol Hepatol; 2003 May; 1(3):219-28. PubMed ID: 15017494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How Serotonin Level Fluctuation Affects the Effectiveness of Treatment in Irritable Bowel Syndrome.
    Vahora IS; Tsouklidis N; Kumar R; Soni R; Khan S
    Cureus; 2020 Aug; 12(8):e9871. PubMed ID: 32968548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuromodulators for Functional Gastrointestinal Disorders (Disorders of Gut-Brain Interaction): A Rome Foundation Working Team Report.
    Drossman DA; Tack J; Ford AC; Szigethy E; Törnblom H; Van Oudenhove L
    Gastroenterology; 2018 Mar; 154(4):1140-1171.e1. PubMed ID: 29274869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current and emerging treatments for irritable bowel syndrome with constipation and chronic idiopathic constipation: focus on prosecretory agents.
    Thomas RH; Luthin DR
    Pharmacotherapy; 2015 Jun; 35(6):613-30. PubMed ID: 26016701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and Safety of Antidepressants for the Treatment of Irritable Bowel Syndrome: A Meta-Analysis.
    Xie C; Tang Y; Wang Y; Yu T; Wang Y; Jiang L; Lin L
    PLoS One; 2015; 10(8):e0127815. PubMed ID: 26252008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of tianeptine on melatonin homeostasis and psychosomatic symptoms in patients with irritable bowel syndrome.
    Chojnacki C; Walecka-Kapica E; Mokwinska M; Romanowski M; Pawlowicz M; Chojnacki J; Klupinska G
    J Physiol Pharmacol; 2013 Apr; 64(2):177-83. PubMed ID: 23756392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective serotonin reuptake inhibitors for the treatment of irritable bowel syndrome.
    Bundeff AW; Woodis CB
    Ann Pharmacother; 2014 Jun; 48(6):777-84. PubMed ID: 24651166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical antipsychotics as a possible treatment option for irritable bowel syndrome.
    Pae CU; Lee SJ; Han C; Patkar AA; Masand PS
    Expert Opin Investig Drugs; 2013 May; 22(5):565-72. PubMed ID: 23506326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A survey of gastroenterologists in the United States on the use of central neuromodulators for treating irritable bowel syndrome.
    Nulsen B; LeBrett W; Drossman DA; Chang L
    Aliment Pharmacol Ther; 2021 Aug; 54(3):281-291. PubMed ID: 34148256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drug therapy's new options in the treatment of the severe irritable bowel syndrome].
    Makarova AA; Ruchkina IN; Diukova GM; Romashkina NV; Indejkina LK; Degterev DA; Parfenov AI
    Ter Arkh; 2023 Oct; 95(8):627-633. PubMed ID: 38158896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin.
    Shekhar C; Monaghan PJ; Morris J; Issa B; Whorwell PJ; Keevil B; Houghton LA
    Gastroenterology; 2013 Oct; 145(4):749-57; quiz e13-4. PubMed ID: 23872499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Visceral sensitivity in diagnostics and treatment of severe irritated bowel syndrome].
    Makarova AA; Diukova GM; Ruchkina IN; Romashkina NV; Indejkina LK; Degterev DA; Dbar SR; Parfenov AI
    Ter Arkh; 2022 Sep; 94(2S):356-361. PubMed ID: 36468983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The new guideline on irritable bowel syndrome: what is new?].
    von Schassen H; Andresen V; Layer P
    Dtsch Med Wochenschr; 2021 Oct; 146(19):1243-1248. PubMed ID: 34553347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The brain-gut axis in irritable bowel syndrome--clinical aspects.
    Mach T
    Med Sci Monit; 2004 Jun; 10(6):RA125-31. PubMed ID: 15173682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of Functional Abdominal Pain With Antidepressants: Benefits, Adverse Effects, and the Gastroenterologist's Role.
    Zar-Kessler CAM; Belkind-Gerson J; Bender S; Kuo BM
    J Pediatr Gastroenterol Nutr; 2017 Jul; 65(1):16-21. PubMed ID: 28644344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of acute serotonergic modulation on rectal motor function in diarrhea-predominant irritable bowel syndrome and healthy controls.
    van Nieuwenhoven MA; Kilkens TO
    Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1259-65. PubMed ID: 22890209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of abdominal pain in irritable bowel syndrome.
    Vanuytsel T; Tack JF; Boeckxstaens GE
    J Gastroenterol; 2014 Aug; 49(8):1193-205. PubMed ID: 24845149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychopharmacology of chronic pain: a focus on antidepressants and atypical antipsychotics.
    Khouzam HR
    Postgrad Med; 2016; 128(3):323-30. PubMed ID: 26821680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in pharmacological treatment of irritable bowel syndrome.
    Lazaraki G; Chatzimavroudis G; Katsinelos P
    World J Gastroenterol; 2014 Jul; 20(27):8867-85. PubMed ID: 25083060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Empirically Supported Use of Psychiatric Medications in Adolescents and Adults with IBD.
    Thorkelson G; Bielefeldt K; Szigethy E
    Inflamm Bowel Dis; 2016 Jun; 22(6):1509-22. PubMed ID: 27167571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.